Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing
Clinical trial NCT03776500 · COMPLETED
Trial details
- NCT number
- NCT03776500
- Sponsor
- Innovative Medicines for Tuberculosis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-21
- Primary completion
- 2020-03-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.